These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 33975191)

  • 1. White matter hyperintensities in patients with Parkinson's disease: A systematic review and meta-analysis.
    Butt A; Kamtchum-Tatuene J; Khan K; Shuaib A; Jickling GC; Miyasaki JM; Smith EE; Camicioli R
    J Neurol Sci; 2021 Jul; 426():117481. PubMed ID: 33975191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
    Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
    Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is white matter hyperintensity burden associated with cognitive and motor impairment in patients with parkinson's disease? A systematic review and meta-analysis.
    Carvalho de Abreu DC; Pieruccini-Faria F; Son S; Montero-Odasso M; Camicioli R
    Neurosci Biobehav Rev; 2024 Jun; 161():105677. PubMed ID: 38636832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
    Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease.
    Ham JH; Lee JJ; Sunwoo MK; Hong JY; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2016 Mar; 24():95-9. PubMed ID: 26776568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periventricular white matter hyperintensity burden and cognitive impairment in early Parkinson's disease.
    Huang X; Wen MC; Ng SY; Hartono S; Chia NS; Choi X; Tay KY; Au WL; Chan LL; Tan EK; Tan LC
    Eur J Neurol; 2020 Jun; 27(6):959-966. PubMed ID: 32124496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and motor correlates of grey and white matter pathology in Parkinson's disease.
    Dadar M; Gee M; Shuaib A; Duchesne S; Camicioli R
    Neuroimage Clin; 2020; 27():102353. PubMed ID: 32745994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter hyperintensities as a predictor of freezing of gait in Parkinson's disease.
    Chung SJ; Lee YH; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2019 Sep; 66():105-109. PubMed ID: 31324555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of age-related white matter hyperintensity with brain atrophy and cognitive impairment in patients with Parkinson's disease].
    Chen HM; Zhang MM; Wang YL
    Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(43):3397-3401. PubMed ID: 33238668
    [No Abstract]   [Full Text] [Related]  

  • 10. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
    Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
    Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
    Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
    J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microstructural Connectivity is More Related to Cognition than Conventional MRI in Parkinson's Disease.
    Lee YH; Lee WJ; Chung SJ; Yoo HS; Jung JH; Baik K; Sohn YH; Seong JK; Lee PH
    J Parkinsons Dis; 2021; 11(1):239-249. PubMed ID: 33074193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's Disease, NOTCH3 Genetic Variants, and White Matter Hyperintensities.
    Ramirez J; Dilliott AA; Binns MA; Breen DP; Evans EC; Beaton D; McLaughlin PM; Kwan D; Holmes MF; Ozzoude M; Scott CJM; Strother SC; Symons S; Swartz RH; Grimes D; Jog M; Masellis M; Black SE; Joutel A; Marras C; Rogaeva E; Hegele RA; Lang AE;
    Mov Disord; 2020 Nov; 35(11):2090-2095. PubMed ID: 32573853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease.
    Liu H; Deng B; Xie F; Yang X; Xie Z; Chen Y; Yang Z; Huang X; Zhu S; Wang Q
    Ann Clin Transl Neurol; 2021 Sep; 8(9):1917-1934. PubMed ID: 34310081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative.
    Carvalho de Abreu DC; Pieruccini-Faria F; Sarquis-Adamson Y; Black A; Fraser J; Van Ooteghem K; Cornish B; Grimes D; Jog M; Masellis M; Steeves T; Nanayakkara N; Ramirez J; Scott C; Holmes M; Ozzoude M; Berezuk C; Symons S; Mohammad Hassan Haddad S; Arnott SR; Binns M; Strother S; Beaton D; Sunderland K; Theyers A; Tan B; Zamyadi M; Levine B; Orange JB; Roberts AC; Lou W; Sujanthan S; Breen DP; Marras C; Kwan D; Adamo S; Peltsch A; Troyer AK; Black SE; McLaughlin PM; Lang AE; McIlroy W; Bartha R; ; Montero-Odasso M
    Eur J Neurol; 2023 Apr; 30(4):920-933. PubMed ID: 36692250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal White Matter Damage Evolution in Parkinson's Disease.
    Scamarcia PG; Agosta F; Spinelli EG; Basaia S; Stojković T; Stankovic I; Sarasso E; Canu E; Markovic V; Petrović I; Stefanova E; Pagani E; Kostic VS; Filippi M
    Mov Disord; 2022 Feb; 37(2):315-324. PubMed ID: 34806799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of white matter hyperintensity on cognitive function in PD patients: a meta-analysis.
    Zhao W; Cheng B; Zhu T; Cui Y; Shen Y; Fu X; Li M; Feng Y; Zhang S
    Front Neurol; 2023; 14():1203311. PubMed ID: 37621858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual rating of white matter hyperintensities in Parkinson's disease.
    Beyer MK; Aarsland D; Greve OJ; Larsen JP
    Mov Disord; 2006 Feb; 21(2):223-9. PubMed ID: 16161159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.